Zur Kurzanzeige

Comorbidity profiles among sputum-positive tuberculosis patients in Cameroon

dc.contributor.authorMagha, Chefor
dc.contributor.authorNchang, Lucy Cho
dc.contributor.authorWeldeslassie, Michael
dc.contributor.authorNkimbeng, Desmond Akumtoh
dc.contributor.authorTchatat, Nancielle Mbiatong
dc.contributor.authorMeriki, Henry Dilonga
dc.contributor.authorDeribe, Kebede
dc.contributor.authorNietcho, Frank Noel
dc.contributor.authorFoyet, Juluis Visnel
dc.contributor.authorFombad, Fanny Fri
dc.contributor.authorKatcho, Tatiana Djikeussi
dc.contributor.authorFru Cho, Jerome
dc.contributor.authorGebremeskel, Eyoab Iyasu
dc.contributor.authorWaddell, Simon J.
dc.contributor.authorBobosha, Kidist
dc.contributor.authorNewport, Melanie J.
dc.contributor.authorHoerauf, Achim
dc.contributor.authorRitter, Manuel
dc.contributor.authorWanji, Samuel
dc.date.accessioned2025-08-06T15:45:25Z
dc.date.available2025-08-06T15:45:25Z
dc.date.issued02.10.2024
dc.identifier.urihttps://hdl.handle.net/20.500.11811/13316
dc.description.abstractIntroduction: Comorbid non-communicable diseases (NCDs) like diabetes, cardiovascular diseases (CVD), kidney diseases, and hypertension, could have implications for tuberculosis (TB) treatment management and increase the disease burden amongst active TB patients.
Methods: This cross-sectional study aimed at profiling comorbidities amongst sputum-positive TB patients in the South West and Littoral regions of Cameroon and was relevant for improving disease management and public health interventions. Diabetes was defined by elevated blood glucose, body mass index (underweight: <18.5 kg/m2, normal: 18.5–<25.0 kg/m2, overweight: 25–<30 kg/m2 and obese: ≥30.0 kg/m2) and hypertension by elevated blood pressure levels (i.e., systolic ≥130 mmHg or diastolic ≥80 mmHg). Socio-demographic and clinical data were collected using case report forms. Descriptive analysis was performed, bivariate logistic regression analysis was computed with at least one comorbidity as the dependent variable (global model) and a multivariable logistic regression analysis was done to provide adjusted odds ratios (final model). The covariate with the highest p-value was removed until p < 0.25 cut-off, using R software version 4.3.1. p-value <0.05 at 95% confidence interval was considered statistically significant.
Results: Five hundred and forty-nine sputum-positive microscopically confirmed active TB patients were enrolled into this study. Two-thirds (65.8%) of the total patients were male. Overall, 56 sputum-positive TB patients had at least one non-communicable disease, thus a prevalence of 10.2% (95% CI = 7.9–13.0). The most frequently recorded NCD was diabetes 4.4% (95% CI = 3.1–6.7) followed by kidney disease 2% (95% CI = 1.1–3.6), hypertension 0.9% (95% CI = 0.4–2.2), and CVD 0.91% (95% CI = 0.4–2.2). Three TB patients (0.6%) had all four comorbidities examined. Age group (p < 0.001), and level of education (p = 0.049) were factors significantly associated with having at least one comorbidity.
Discussion: Our findings showed that diabetes was significantly the most prevalent comorbid NCD amongst sputum-positive TB patients (p < 0.001). HIV status, occupation, body mass index (BMI), and alcohol intake were not significantly associated with having at least one comorbidity. Implementing public health intervention programmes such as systematic screening of TB patients for NCDs especially diabetes is highly recommended for better control of these diseases.
en
dc.format.extent10
dc.language.isoeng
dc.rightsNamensnennung 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectMycobacterium tuberculosis
dc.subjectcomorbidities
dc.subjectnon-communicable diseases
dc.subjecttuberculosis
dc.subjectdiabetes
dc.subjectcardiovascular disease
dc.subjectkidney disease
dc.subject.ddc570 Biowissenschaften, Biologie
dc.subject.ddc610 Medizin, Gesundheit
dc.titleComorbidity profiles among sputum-positive tuberculosis patients in Cameroon
dc.typeWissenschaftlicher Artikel
dc.publisher.nameFrontiers Media SA
dc.publisher.locationLausanne
dc.rights.accessRightsopenAccess
dcterms.bibliographicCitation.volume2024, vol. 2
dcterms.bibliographicCitation.issue1433856
dcterms.bibliographicCitation.pagestart1
dcterms.bibliographicCitation.pageend10
dc.relation.doihttps://doi.org/10.3389/ftubr.2024.1433856
dcterms.bibliographicCitation.journaltitleFrontiers in Tuberculosis
ulbbn.pubtypeZweitveröffentlichung
dc.versionpublishedVersion
ulbbn.sponsorship.oaUnifundOA-Förderung Universität Bonn


Dateien zu dieser Ressource

Thumbnail

Das Dokument erscheint in:

Zur Kurzanzeige

Die folgenden Nutzungsbestimmungen sind mit dieser Ressource verbunden:

Namensnennung 4.0 International